Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
Public ClinicalTrials.gov record NCT03704766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03704766
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Hospital for Special Surgery, New York
- Other
- Enrollment
- 442 participants
Conditions and interventions
Conditions
Interventions
- Blood Cultures Diagnostic Test
- Optional blood testing per standard of care (ASO, anti-strep, ANA, anti-DS-DNA, HLA-B27, RF, Lyme and other inflammatory/ rheumatologic markers ) Diagnostic Test
- Serum C-reactive Protein (CRP) Diagnostic Test
- Serum Cell count + differential (CBC) Diagnostic Test
- Serum D-dimer Diagnostic Test
- Serum Procalcitonin Diagnostic Test
- Serum erythrocyte sedimentation rate (ESR) Diagnostic Test
- Synovial Alpha-defensin assay Diagnostic Test
- Synovial C-reactive Protein (CRP) Diagnostic Test
- Synovial Candida spp antigen panel Diagnostic Test
- Synovial Cell count + differential (CBC) Diagnostic Test
- Synovial Enterococcus faecalis assay Diagnostic Test
- Synovial Gram Stain Diagnostic Test
- Synovial Leukocyte Esterase Test Strips Diagnostic Test
- Synovial Neutrophil elastase assay Diagnostic Test
- Synovial PCR for Kingella kingae Diagnostic Test
- Synovial Staphylococcus spp antigen panel Diagnostic Test
- Synovial bacterial culture by BacT/Alert Diagnostic Test
- Synovial lactate assay Diagnostic Test
Diagnostic Test
Eligibility (public fields only)
- Age range
- Up to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 27, 2016
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
- Last update posted
- Jun 21, 2025
2016 – 2026
United States locations
- U.S. sites
- 3
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Healthcare of Atlanta | Atlanta | Georgia | 30342 | Recruiting |
| Hospital for Special Surgery | New York | New York | 10021 | Recruiting |
| Campbell Clinic | Collierville | Tennessee | 38017 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03704766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03704766 live on ClinicalTrials.gov.